IgG4-related conditions affecting the digestive tract are part of a multi-organ fibro-
inflammatory disorder termed IgG4-related disease (IgG4-RD), with autoimmune pancreatitis …

In response to the latest knowledge and the amendment of the Japanese diagnostic criteria
for autoimmune pancreatitis (AIP) in 2018, the Japanese consensus guidelines for …

The overall objective of these guidelines is to provide evidence-based recommendations for
the diagnosis and management of immunoglobulin G4 (IgG4)-related digestive disease in …

Objectives This randomized, controlled clinical trial aims to compare the efficacy and safety
of glucocorticoid combined with MMF and glucocorticoid monotherapy for patients with IgG4 …

Objectives The aim of this study was to investigate the predictive factors for relapse of IgG4‐
related disease (IgG4‐RD) and observe the long‐term clinical outcomes in patients with …

BACKGROUND Autoimmune pancreatitis (AIP) has been linked with elevated
immunoglobulin (Ig) G4 levels. The characteristics and outcomes of AIP based on serum …

Purpose of review Recent studies have documented that many patients with pancreatic
exocrine insufficiency (EPI) are not identified and are not treated with appropriate dosages …

Background IgG4-related kidney disease is a major manifestation of IgG4-related disease, a
systemic fibroinflammatory disorder. However, the clinical and prognostic kidney-related …

Autoimmune pancreatitis (AIP), a unique subtype of pancreatitis, is often accompanied by
systemic inflammatory disorders. AIP is classified into two distinct subtypes on the basis of …

Abstract Background and Aim The study aims to determine and quantify the stratified risk of
recurrent pancreatitis (RP) after the first episode of acute pancreatitis in relation to etiology …